Xiaopei J. Wang

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.

Journal: American journal of hematology

Published: February 19, 2026

Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.

Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.

Journal: American journal of hematology

Published: February 04, 2026

A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study).

A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study).

Journal: Bone marrow transplantation

Published: January 28, 2026

Clinical Characteristics and Prognosis of Primary Central Nervous System Lymphoma: A Retrospective Analysis.

Clinical Characteristics and Prognosis of Primary Central Nervous System Lymphoma: A Retrospective Analysis.

Journal: Cancers

Published: January 10, 2026

Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China.

Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China.

Journal: Journal of Cancer

Published: August 22, 2023

Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.

Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 08, 2022

Up-front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra-nodal NKT cell lymphoma: A multicenter real-world study in China.

Up-front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra-nodal NKT cell lymphoma: A multicenter real-world study in China.

Journal: European journal of haematology

Published: November 30, 2022

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis.

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis.

Journal: Frontiers in oncology

Published: September 08, 2022

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.

Journal: Cancer medicine

Published: August 01, 2022

Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.

Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.

Journal: Bone marrow transplantation

Published: July 29, 2022

The Clonal Diversity of Peripheral B Cell Receptor Immune Repertoire Impaired by Residual Malignant B Cells Predicts Treatment Efficacy in B Cell Lymphoma Patients.

The Clonal Diversity of Peripheral B Cell Receptor Immune Repertoire Impaired by Residual Malignant B Cells Predicts Treatment Efficacy in B Cell Lymphoma Patients.

Journal: Cancers

Published: July 17, 2022

Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.

Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.

Journal: Bone marrow transplantation

Published: June 11, 2022

Showing 1-12 of 57

Last Updated: 09/26/2026